These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31856583)
1. Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Noseda R; Schain AJ; Melo-Carrillo A; Tien J; Stratton J; Mai F; Strassman AM; Burstein R Cephalalgia; 2020 Mar; 40(3):229-240. PubMed ID: 31856583 [TBL] [Abstract][Full Text] [Related]
3. Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody. Melo-Carrillo A; Noseda R; Nir RR; Schain AJ; Stratton J; Strassman AM; Burstein R J Neurosci; 2017 Jul; 37(30):7149-7163. PubMed ID: 28642283 [TBL] [Abstract][Full Text] [Related]
4. Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat. Friedrich N; Németh K; Tanner M; Rosta J; Dobos I; Oszlács O; Jancsó G; Messlinger K; Dux M J Headache Pain; 2024 Jan; 25(1):9. PubMed ID: 38243174 [TBL] [Abstract][Full Text] [Related]
5. The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow. Dux M; Vogler B; Kuhn A; Mackenzie KD; Stratton J; Messlinger K Cells; 2022 May; 11(11):. PubMed ID: 35681463 [TBL] [Abstract][Full Text] [Related]
6. C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system. Edvinsson JCA; Warfvinge K; Krause DN; Blixt FW; Sheykhzade M; Edvinsson L; Haanes KA J Headache Pain; 2019 Nov; 20(1):105. PubMed ID: 31718551 [TBL] [Abstract][Full Text] [Related]
7. CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura. Schain AJ; Melo-Carrillo A; Stratton J; Strassman AM; Burstein R J Neurosci; 2019 Jul; 39(30):6001-6011. PubMed ID: 31127003 [TBL] [Abstract][Full Text] [Related]
8. Visualizing the Calcitonin Gene-Related Peptide Immunoreactive Innervation of the Rat Cranial Dura Mater with Immunofluorescence and Neural Tracing. Wang J; Xu D; Cui J; She C; Wang H; Wu S; Zou L; Zhang J; Bai W J Vis Exp; 2021 Jan; (167):. PubMed ID: 33491673 [TBL] [Abstract][Full Text] [Related]
9. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Edvinsson L; Warfvinge K Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807 [TBL] [Abstract][Full Text] [Related]
11. Evidence for CGRP re-uptake in rat dura mater encephali. Gupta S; Amrutkar DV; Mataji A; Salmasi H; Hay-Schmidt A; Sheykhzade M; Messlinger K; Olesen J; Jansen-Olesen I Br J Pharmacol; 2010 Dec; 161(8):1885-98. PubMed ID: 20804493 [TBL] [Abstract][Full Text] [Related]
12. Glycerol Trinitrate Acts Downstream of Calcitonin Gene-Related Peptide in Trigeminal Nociception-Evidence from Rodent Experiments with Anti-CGRP Antibody Fremanezumab. Benedicter N; Vogler B; Kuhn A; Schramm J; Mackenzie KD; Stratton J; Dux M; Messlinger K Cells; 2024 Mar; 13(7):. PubMed ID: 38607011 [TBL] [Abstract][Full Text] [Related]
13. Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood-brain barrier. Melo-Carrillo A; Schain AJ; Stratton J; Strassman AM; Burstein R Pain; 2020 May; 161(5):1037-1043. PubMed ID: 31895266 [TBL] [Abstract][Full Text] [Related]
14. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model. Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278 [TBL] [Abstract][Full Text] [Related]
16. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies. Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150 [TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of sensory and autonomic innervation of the dog tongue with special reference to substance P- and calcitonin gene-related peptide-containing fibers in blood vessels and the intralingual ganglia. Hino N; Masuko S; Katsuki T Arch Histol Cytol; 1993 Dec; 56(5):505-16. PubMed ID: 7510508 [TBL] [Abstract][Full Text] [Related]
19. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier. Eftekhari S; Salvatore CA; Johansson S; Chen TB; Zeng Z; Edvinsson L Brain Res; 2015 Mar; 1600():93-109. PubMed ID: 25463029 [TBL] [Abstract][Full Text] [Related]
20. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Ma QP; Hill R; Sirinathsinghji D Eur J Neurosci; 2001 Jun; 13(11):2099-104. PubMed ID: 11422450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]